| Turkey | Austria | Spain | |
| Immunotherapy with Keytruda (Pembolizumab) | from $7,300 | from $15,000 | from $15,000 |
Medically reviewed by
Fahad MawloodProf. Dr. Eda Şimşek Tanrıkulu specializes in medical oncology and immunotherapy with training affiliations at Johns Hopkins Hospital. Keytruda immunotherapy at Anadolu Medical Center may cost around 160,000 TRY per cycle – typically covering the medication and daily inpatient fees. The JCI-accredited hospital follows ESMO standards and offers tumor board planning for personalized treatment protocols.
Day 1
Day 2
Day 3
Day 4-5
Day 6
Day 7
Weeks 2-4
Please note that each patient"s experience may vary, and you should always follow the advice of your healthcare provider.
Keytruda, a form of immune-based therapy, leverages the body's immune system to target and destroy cancer cells using monoclonal antibodies.
Pembrolizumab belongs to the group of the immunotherapy drugs — type of medicine that can treat certain cancers by influencing on patient's immune system. It blocks a protective mechanism of cancer cells and allows the immune system to destroy them. Monoclonal antibody to programmed cell death-1 protein (PD-1) blocks the interaction between PD-1 and its ligands — PD-L1 and PD-L2.
Keytruda prices are specified in this listing. Submit a request to get a personalized quote.
On May 23, 2017, the U.S. Food and Drug Administration granted for Pembrolizumab (Keytruda) an accelerated approval — faster approval of drugs for serious conditions that fill an unmet medical need. FDA allowed prescribing immunotherapy new drug to treat patients whose cancers have a specific genetic feature (biomarker).
During the clinical trials of Keytruda, the following indicators were achieved:
|
Period |
The survival rate of patients with 3-4 stages of cancer |
|
6 month |
92% |
|
1 year |
69% |
|
1,5 years |
62% |
|
2 years |
58% |
The manufacturer is Merck & Co., Inc. — an American pharmaceutical company and one of the largest pharmaceutical companies in the world. Research performed at Merck has led to FDA approval of 63 new drugs. Company has developed more new drugs than any other company in the USA.